TARO-GLICLAZIDE MR: may contain the presence of pink coloured stain (identified as Candesartan Cilexetil)
Brand(s)
Last updated
Summary
Product
TARO-GLICLAZIDE MR
Issue
Health products - Product safety
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
TARO-GLICLAZIDE MR |
TARO-GLICLAZIDE MR |
DIN 02439328 |
Tablet (Extended-Release) |
GLICLAZIDE 60 MG |
PTF5132A |
Issue
Affected lot may contain the presence of pink coloured stain (identified as Candesartan Cilexetil).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Sun Pharma Canada Inc.
126 East Drive,
Brampton, ON
L6T 1C1
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-77490
Get notified
Receive notifications for new and updated recalls and alerts by category.